Leukaemia Chatters

After giving birth to her second daughter, Heidi began to experience night sweats and was overwhelmed with fatigue. A few months later, Heidi was diagnosed with acute myeloid leukaemia (AML) and was unable to work, resulting in her and her husband struggling to care for their family of four. Here, she tells her story…

On this episode on Leukaemia Chatters, we spoke to Emma Sinclair a CML patient diagnosed in 2021. We talked to Emma about the events that led up to her diagnosis, the changes that have come with living with a chronic leukaemia and the support and help she has turned to over the last 18 months.

On this episode of Leukaemia Chatters we spoke to Zack Pemberton Whiteley, Leukaemia Care's CEO live from the ASH conference. We discussed some of the newest developments in the treatment of leukaemia and how they might change the landscape for patients in the coming years.

On this episode on Leukaemia Chatters, we spoke to Dan Chapman a CML patient diagnosed in 2015. We talked to Dan about the events that led up to his diagnosis, the impact of a chronic leukaemia on his life and the challenges he has taken on to fundraise for Leukaemia Care.

On this episode on Leukaemia Chatters, we spoke to Lisa Southall 10 years down the line from her diagnosis with Essential Thrombocythaemia. We talked to Lisa all about her period of diagnosis 10 years ago, the complications she faced through her treatment and the support and help she has relied upon for the past decade of living with a blood cancer.

On this month's episode on Leukaemia Chatters, we spoke to Majella Murphy on the 4 year anniversary of her diagnosis with AML. As well as marking this personal anniversary for Majella, September is also Blood Cancer Awareness Month and as such Leukaemia Care's #SpotLeukaemia campaign is in full effect as we showcase patient stories and highlight the symptoms that the public should look out for. We talked to Majella all about her period of diagnosis 4 years ago as she noticed these symptoms in her day to day life, how she navigated the healthcare system to receive her diagnosis and the impact it had on her and her family.

On this month's episode of Leukaemia Chatters as we lead up to the #SpotLeukaemia campaign we talked to Eilidh Ann Dewar, an APML patient diagnosed in 2018. We talked to Eilidh Ann about her rapidly accelerating symptoms, how she had to pursue them and the impact that such an out of the blue diagnosis had on her and her family.

On this episode of Leukaemia Chatters, we spoke to AML patient Debbie Greenwood. We discuss the impact of her 2020 diagnosis on herself and her family, the support they have received since then and how Debbie is going on to provide help for patients and their families who find themselves in a similar situation.

In this episode of Leukaemia Chatters we spoke to our new poet-in-residence Jamie Woods, an acute promyelocytic leukaemia (APL) patient. We spoke to Jamie about the power over poetry, how it's impacted his experience with leukaemia and what he hopes to achieve in the role.

In this month's episode, we mark the ten-year anniversary of Peter's stem cell transplant he received from his donor David. We discussed Peter's initial diagnosis with MDS, the reality of the transplant process from both of their perspectives and how that day has come to impact both of their lives.

On this episode of Leukaemia Chatters, we chatted with chronic lymphocytic leukaemia (CLL) patient Helen Wood, who spent two years after diagnosis on Watch and Wait. As a part of this April's Left to #WatchWaitWorry campaign, Helen shares her experiences of coming to terms with Watch and Wait, the resources and support that were available to her during this time and what she thinks needs to improve for patients in the UK.

In this month's Leukaemia Chatters podcast, we talk to Bailey about his childhood diagnosis of acute lymphoblastic leukaemia (ALL), his journey into acting, and the notable stops he's made along the way including Watford Square, and most recently, the set of Bridgerton season 2.

In this month's episode we talk about Kes' struggle to get a diagnosis, how she handled active monitoring/ Watch and Wait and the wider impact her stem cell transplant has had on her life.

This month we chatted to Naomi Roberts about being diagnosed 3 days before the first lockdown in March 2020, her experience with stem cell transplant and the impact on her time at university

In this month's edition of Leukaemia Chatters we spoke to Anthony Hyde about his chronic myeloid leukaemia (CML) diagnosis, which happened to be during the festive season, how he went on to write his own book following his CML experience and more.

In this month's edition of Leukaemia Chatters we spoke to Nick York, LC's very own Patient Advocacy Healthcare Liaison Officer and chronic lymphocytic leukaemia(CLL) patient. We talked to Nick about the methods he's used to protect himself as an immunocompromised person, the isolating impact of shielding and how he plans on spending Christmas.

On this month's episode of Leukaemia Chatters we spoke to Dharmesh Mehta, LC Trustee and CML patient. We chatted about how he came to be diagnosed, jumping out of a plane in the name of fundraising and the steps he took to get to grips with his CML.

In this final podcast for blood cancer awareness month we spoke to acute lymphoblastic leukaemia (ALL)patient Bansri Dhokia. We chatted to Bansri about her experience getting diagnosed mid-pandemic, her treatment and stem cell transplant and her desire to get the BAME community talking about blood cancer.

STV News Reporter Laura Boyd was diagnosed with chronic myeloid leukaemia (CML) in September 2009. This #WorldCMLDay, Laura was kind enough to speak to our Patient Advocacy Manager Charlotte on our podcast Leukaemia Chatters! They talk about how she was diagnosed, the impact of her leukaemia on her attempts to have a child, the reality of living with a chronic leukaemia and more.

We chatted to Wilfred Emmanuel-Jones MBE about his life, the turns of his career that have culminated in his "The Black Farmer" range, and his diagnosis and treatment of acute myeloid leukaemia (AML)